l-cysteine (cysteine hydrochloride) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Cysteine (cysteine hydrochloride is a salt) is a thiol-containing amino acid that is oxidized to form cystine. Cysteine is synthesized from methionine via the trans-sulfuration pathway in the adult, but newborn infants lack the enzyme, cystathionase, necessary to effect this conversion. Therefore, cysteine is generally considered to be an essential amino acid in infants.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$54.5830 - $72.8640
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

(2r)-2-amino-3-mercaptopropanoic acid | (2r)-2-amino-3-sulfanylpropanoic acid | cys | cystein | cysteine | cysteine hcl | cysteine hydrochloride | e920 | e921 | free cysteine | l-2-amino-3-mercaptopropionic acid | l-cys | l-cystein | l-cysteine | l-cysteine ethylester hcl | l-cysteinemethyl hcl | l-zystein | (r)-2-amino-3-mercaptopropanoic acid | (r)-cysteine

Organizations (31)

Research & Development (22)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (9)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (12)

Approved Indications (1)


 

Parenteral Nutrition (approved 1986)

Experimental Indications - Clinical Trial Phases 1-4 (11)


 

Arthritis, Rheumatoid (Phase 3)

Bronchopulmonary Dysplasia (Phase 2/Phase 3)

Enterocolitis, Necrotizing (Phase 2/Phase 3)

Gastritis, Atrophic (Phase 2)

Healthy Volunteers (Phase 1)

Protoporphyria, Erythropoietic (Phase 3)

Retinopathy of Prematurity (Phase 2/Phase 3)

Sepsis (Phase 2/Phase 3)

Systemic Inflammatory Response Syndrome (Phase 2/Phase 3)

Uremia (Phase 2)

Vitamin D Deficiency (Early Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 13
  • # of Trial Organizations: 22

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue